What is Ande?
ANDE is recognized globally as the foremost provider of Rapid DNA technology. The company's core mission revolves around leveraging Rapid DNA to foster a safer world, with its pioneering advancements making significant impacts across law enforcement, military operations, and disaster victim identification sectors, both domestically and internationally. Founded in 2004, ANDE operates from offices in Waltham, MA; Longmont, CO; and Washington, D.C. The ANDE System has achieved critical approvals, including FBI NDIS approval for generating DNA IDs from cheek swabs and Department of Defense approval for processing a wide array of forensic and disaster victim sample types.
How much funding has Ande raised?
Ande has raised a total of $18M across 2 funding rounds:
Private Equity
$16M
Debt
$2M
Private Equity (2017): $16M, investors not publicly disclosed
Debt (2020): $2M led by PPP
What's next for Ande?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for ANDE. This capital infusion is expected to accelerate the company's expansion into new markets and further develop its cutting-edge Rapid DNA technologies. With a strong foundation in law enforcement and defense, ANDE is well-positioned to capitalize on the increasing global demand for rapid and accurate DNA identification solutions, potentially solidifying its market leadership and driving further innovation in forensic science.
See full Ande company page
